期刊文献+

非ST段抬高急性冠状动脉综合征患者血浆心肌肌钙蛋白T的变化及意义

下载PDF
导出
摘要 本研究采用Roche公司Elecsys2010电化学发光系统,检测200例非ST段抬高急性冠状动脉综合征(NSTEACS)患者血浆心肌肌钙蛋白T(cTnT)含量,并初步探讨cTnT在非ST段抬高心肌梗死(NSTEMI)中的意义、变化及其在NSTEACS危险分层中的意义。
出处 《诊断学理论与实践》 2008年第1期83-85,共3页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献11

  • 1[1]Wu AHB,Apple FS,Giber WB,et al.National academy of clinical biochemistry standards of cabomtory practice:recommendations for the use of cardiac markers in coronary artery diseases[J].Clin Chem,1999,45(7):1104-1121.
  • 2[2]Braunwald E.Classification of unstable angina[J].Circulation,1989,80(2):410-414.
  • 3[3]Nationnal Committee for Clinioal Laboratory Standards.Evaluation of precision performance of clinical chemistry devices;Approved guideline NCCLS,Docment EP5-A.Wayne,PA:NCCLS[J],1999(1):1-42.
  • 4潘柏申,杨振华,吴健民.冠状动脉疾病和心力衰竭时心脏标志物临床检测应用建议[J].中华检验医学杂志,2006,29(9):774-778. 被引量:73
  • 5[5]Hamm C W,Bertrand M,Braunwald E.Acute coronary syndromes without ST elevation:implemenntatioof new guidelires[J].Lancet,2001,358(10):1533-1538.
  • 6柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 7[7]Dean KJ.Biochemistry and molecular biology of troponin I and T[M].In:Cardiac markers.ed.AHB Wu.Humana Press Inc.New Jersey,1998.193-204.
  • 8[8]Braunwald E.Classification of Unstable ang[J].Circulation,1989,80(2):410-414.
  • 9[9]Antman EM,Tanasijevie MJ,Thompson B,et al.Cardiacspecific troponin T level to predict of mortality in patients with acute coronary syndromes[J].N Engl J Med,1996,335(9):1342-1349.
  • 10[10]Rottbauer W,Geten T,Muller-Bardorff M,et al.Troponin T a diagnosyic marker for myocardial infarction and minor cardiac cell domage[J].Eur Heart J,1996,17(1):3-8.

二级参考文献57

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Pearson TA, Mensah GA, Hong Y, et al. CDC/AHA Workshop on markers of inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice : Overview. Circulation, 2004,110 : e543-544.
  • 3Myers GL,Rifai N,Tracy RP,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation ,200d, 110 :e545-549.
  • 4Smith SC Jr, Anderson JL, Cannon RO 3rd, et al. CDC/AHA Workshop on Markers of inflammation and Cardiovascular Disease:Application to Clinical And Public Health Practice: report from the clinical practice discussion group. Circulation,2004, 110 : e550-553.
  • 5Fortmann SP, Ford E, Criqui MH, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation,2004, 110 : e554-559.
  • 6Biasucci LM, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease : Application to Clinical and Public Health practice: clinical use of inflammatory markers in Patients with cardiovascular diseases : a background paper.Circulation ,2004, 110 :e560-567.
  • 7Wilson PW, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation,2004,110:e568-571.
  • 8Roberts WL, CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Application to Clinical and Public Health Practice. laboratory tests available to assess inflammation-performance and standardization: a background paper.Circulation, 2004,110 :e572-578.
  • 9Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation, 2003,108:250-252.
  • 10Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem, 1999,45:18-20.

共引文献2177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部